All intellectual and work property derived from DiagnaMed’s research activities in amyotrophic lateral sclerosis (ALS) and its Orphan Drug Designation (ODD) for molecular hydrogen in the treatment of ...

A genomic study of hydrogen-producing bacteria has revealed entirely new gene clusters capable of producing large volumes of ...

Revive Therapeutics (RVVTF) it has entered into an asset purchase agreement dated March 31 with DiagnaMed to acquire the full rights to ...

A genomic study of hydrogen-producing bacteria has revealed entirely new gene clusters capable of producing large volumes of hydrogen.

These trends match our recent experience advising on hydrogen matters. One green hydrogen pathway is evolving to take the ...

Hydrogen tanks and tech have been part of the stable at Swagelok for many years, and van den Burg himself has nearly 20 years ...

Scientists have long understood the primary way H₃⁺ forms—when a hydrogen molecule (H₂) collides with its ionized counterpart, H₂⁺. However, recent research suggests that alternative ...

All intellectual and work property derived from DiagnaMed’s research activities in amyotrophic lateral sclerosis (ALS) and its Orphan Drug Designation (ODD) for molecular hydrogen in the ...